Market Cap | 12.91M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -28.75M | Forward P/E | -5.56 | EPS next Y | - | 50D Avg Chg | -15.00% |
Sales | 37.16M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -45.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -87.00% |
Recommedations | 2.00 | Quick Ratio | 0.15 | Shares Outstanding | 10.30M | 52W Low Chg | 17.00% |
Insider Own | 61.10% | ROA | -40.39% | Shares Float | 4.24M | Beta | 5.39 |
Inst Own | 2.30% | ROE | - | Shares Shorted/Prior | 116.62K/212.52K | Price | 1.78 |
Gross Margin | 34.76% | Profit Margin | -77.38% | Avg. Volume | 146,977 | Target Price | 6.00 |
Oper. Margin | -44.81% | Earnings Date | May 10 | Volume | 273,133 | Change | -4.30% |
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services. It also develops artificial intelligence and healthcare technology. Marpai, Inc. was incorporated in 2021 and is headquartered in New York, New York.
Maxim Group | Buy | Mar 28, 24 |
Maxim Group | Hold | Nov 15, 23 |
Maxim Group | Hold | Nov 14, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Lamendola Damien | Chief Executive Offi.. Chief Executive Officer | Jan 16 | Buy | 0.9201 | 1,100,000 | 1,012,110 | 1,951,306 | 01/17/24 |
PONS ROBERT M | Director Director | Jan 16 | Buy | 0.92 | 12,100 | 11,132 | 24,200 | 01/17/24 |
EITAN YARON | Director Director | Jan 16 | Buy | 0.9201 | 210,000 | 193,221 | 601,454 | 01/17/24 |
Lamendola Damien | Chief Executive Offi.. Chief Executive Officer | Dec 14 | Buy | 1.97 | 150,000 | 295,500 | 851,306 | 12/18/23 |
PONS ROBERT M | Director Director | Dec 14 | Buy | 1.81 | 12,100 | 21,901 | 12,100 | 12/18/23 |
EITAN YARON | Director Director | Dec 14 | Buy | 1.97 | 50,000 | 98,500 | 391,454 | 12/14/23 |
Gonzalez Edmundo | Chief Executive Offi.. Chief Executive Officer | Sep 11 | Buy | 0.77 | 42,000 | 32,340 | 264,047 | 09/12/23 |
Gonzalez Edmundo | Chief Executive Offi.. Chief Executive Officer | Nov 15 | Buy | 0.95 | 9,110 | 8,654 | 868,189 | 11/17/22 |
Lamendola Damien | Director Director | Aug 22 | Buy | 1.03 | 292,255 | 301,023 | 2,705,223 | 08/24/22 |
Lamendola Damien | Director Director | Aug 17 | Buy | 0.84 | 250,000 | 210,000 | 2,412,968 | 08/19/22 |
EITAN YARON | Director Director | Aug 18 | Buy | 0.79 | 175,000 | 138,250 | 965,816 | 08/18/22 |
Kane Vincent | Director Director | Aug 17 | Buy | 0.8 | 6,500 | 5,200 | 71,169 | 08/18/22 |
EITAN YARON | Director Director | Aug 17 | Buy | 0.79 | 31,000 | 24,490 | 790,816 | 08/17/22 |
Brown Ronnie | Chief Operating Offi.. Chief Operating Officer | May 18 | Buy | 1.4386 | 694 | 998 | 694 | 05/19/22 |
Gonzalez Edmundo | Chief Executive Offi.. Chief Executive Officer | May 18 | Buy | 1.1937 | 9,000 | 10,743 | 849,079 | 05/19/22 |
EITAN YARON | Director Director | May 16 | Buy | 1.2 | 30,473 | 36,568 | 690,289 | 05/18/22 |
Kane Vincent | Director Director | May 16 | Buy | 1.05 | 10,000 | 10,500 | 64,669 | 05/17/22 |